International patterns and trends in the brain cancer incidence and mortality: An observational study based on the global burden of disease
- PMID: 37519769
- PMCID: PMC10372320
- DOI: 10.1016/j.heliyon.2023.e18222
International patterns and trends in the brain cancer incidence and mortality: An observational study based on the global burden of disease
Abstract
Background: Brain cancer is a serious issue in the global burden of diseases. This observational research aimed to assess trends of the brain cancer incidence and mortality in the world in the period 1990-2019.
Methods: Brain cancer incidence and mortality data were retrieved from the Global Burden of Disease 2019 study database. The joinpoint regression analysis was done to assess the brain cancer indicence and mortality trends: the average annual percent change (AAPC) along with its 95% confidence interval (95% CI) was calculated.
Results: In both sexes, the highest age-standardized rates of incidence and mortality were found in high-income regions (Europe and America), while the lowest were observed in the African Region. A significant rise in brain cancer incidence rates both in males and females was observed in all regions, with one exception of a significantly decreased trend only among males in the South-East Asia Region. Among countries with increased trends in incidence and mortality from brain cancer, Cuba experienced the most marked increase in both incidence (AAPC = +5.7% in males and AAPC = +5.4% in females) and mortality rates (AAPC = +5.5% in males and AAPC = +5.1% in females). Among countries that experienced a decline in brain cancer incidence and mortality, Hungary and Greenland showed the most marked decline in both sexes (equally by -1.0%).
Conclusion: Brain cancer shows increasing global incidence rates in both sexes and represents a priority for prevention and further research.
Keywords: Brain cancer; Incidence; Joinpoint analysis; Mortality; Trend.
© 2023 The Authors. Published by Elsevier Ltd.
Conflict of interest statement
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures








References
-
- Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca - Cancer J. Clin. 2021;71(3):209–249. - PubMed
-
- Siegel R.L., Miller K.D., Fuchs H.E., Jemal A. Cancer statistics, 2022. Ca - Cancer J. Clin. 2022;72(1):7–33. - PubMed
-
- Ferlay J., Colombet M., Bray F. International Agency for Research on Cancer; Lyon, France: 2018. Cancer incidence in five continents, CI5plus: IARC CancerBase No. 9.http://ci5.iarc.fr Available from: Accessed on: 07/08/2022.
-
- Howlader N., Noone A.M., Krapcho M., Miller D., Brest A., Yu M., et al., editors. Based on November 2020 SEER Data Submission, Posted to the SEER Web Site, April 2021. National Cancer Institute; Bethesda, MD: 1975-2018. SEER cancer statistics review.https://seer.cancer.gov/csr/1975_2018/ Available from: Accessed on: 22/08/2022.
-
- Global Burden of Disease Cancer Collaboration Global, regional, and national cancer incidence, mortality, years of life Lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study. JAMA Oncol. 2019;5:1749–1768. - PMC - PubMed
LinkOut - more resources
Full Text Sources